Editorial Board: Arch Pharm (6/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202270013
- Publication type:
- Article
Works in Archiv der Pharmazie, 2022, Vol 355, Issue 6
Results: 15
1
2
Cover Picture: Arch Pharm (6/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202270012
- Publication type:
- Article
3
Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202200051
- By:
- Publication type:
- Article
4
Synergistic effect of compounds directed to triosephosphate isomerase, a combination to develop drug against trichomoniasis.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202200046
- By:
- Publication type:
- Article
5
Cyanopropyl functionalized benzimidazolium salts and their silver N‐heterocyclic carbene complexes: Synthesis, antimicrobial activity, and theoretical analysis.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202200041
- By:
- Publication type:
- Article
6
Design, synthesis, and biological evaluation of isatin‐indole‐3‐carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202200033
- By:
- Publication type:
- Article
7
Synthesis of oxazolo‐annulated 3‐benzazepines designed by merging two negative allosteric NMDA receptor modulators.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202200020
- By:
- Publication type:
- Article
8
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202200009
- By:
- Publication type:
- Article
9
Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202100506
- By:
- Publication type:
- Article
10
Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202100481
- By:
- Publication type:
- Article
11
Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202100476
- By:
- Publication type:
- Article
12
Recent green approaches for the synthesis of pyrazolo[3,4‐d]pyrimidines: A mini review.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202100470
- By:
- Publication type:
- Article
13
Thiophene‐containing compounds with antimicrobial activity.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202100462
- Publication type:
- Article
14
Acridinium‐conjugated aromatic heterocycles as highly potent FtsZ inhibitors: Design, synthesis, and biological evaluation.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202100400
- By:
- Publication type:
- Article
15
Antitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 6, p. 1, doi. 10.1002/ardp.202100327
- By:
- Publication type:
- Article